Literature DB >> 589862

A test for antigen--antibody complexes in human sera using IgM of rabbit antisera to human immunoglobulins.

R J Levinsky, J F Soothill.   

Abstract

A simple semi-quantitative test for soluble antigen--antibody complexes using characterized non-human reagents and permitting analysis of their constituents is described. The agglutination of immunoglobulin-coated latex particles by rabbit IgM antibodies to the immunoglobulin is inhibited by complex-containing sera. No inhibition is obtained with monomer immunoglobulins. Semi-quantitative measurement of complexes may be made by electronically counting residual unagglutinated latex particles. The new method of linking proteins to latex by DNP coupling permits the technique to be applied to all constituents of complexes; immunoglobulins, complement and antigens. A new method of decomplementing sera by EDTA-Sigma cell-IgG absorption allows analysis of sera without the false positives and false negatives other methods give. The test gave positive results for IgG complexes in most of twenty-four patients with SLE nephritis. IgA complexes were identified in a patient with Henoch-Schonlein purpura nephritis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 589862      PMCID: PMC1541081     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Agglutinating activity of the complement component C'1q in the F-II latex fixation test.

Authors:  R W Ewald; A F Schubart
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

3.  Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

Authors:  K Yonemasu; R M Stroud
Journal:  J Immunol       Date:  1971-02       Impact factor: 5.422

4.  Serum immune complexes and disease activity in lupus nephritis.

Authors:  R J Levinsky; J S Cameron; J F Soothill
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

5.  The specificity and polyvalency of binding of a monoclonal rheumatoid factor.

Authors:  R Eisenberg
Journal:  Immunochemistry       Date:  1976-04

6.  Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.

Authors:  A Z Lurhuma; C L Cambiaso; P L Masson; J F Heremans
Journal:  Clin Exp Immunol       Date:  1976-08       Impact factor: 4.330

7.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  Detection of circulating immune complexes in pathological human sera.

Authors:  A H Johnson; J F Mowbray; K A Porter
Journal:  Lancet       Date:  1975-04-05       Impact factor: 79.321

9.  The binding constants of IgM rheumatoid factors and their univalent fragments for native and aggregated human IgG;.

Authors:  S Dissanayake; F C Hay; I M Roitt
Journal:  Immunology       Date:  1977-03       Impact factor: 7.397

10.  C1q deviation test for the detection of immune complexes, aggregates of IgG, and bacterial products in human serum.

Authors:  A T Sobel; V A Bokisch; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1975-07-01       Impact factor: 14.307

  10 in total
  17 in total

Review 1.  Role of circulating soluble immune complexes in disease.

Authors:  R J Levinsky
Journal:  Arch Dis Child       Date:  1978-02       Impact factor: 3.791

2.  Circulating immune complexes in mucocutaneous lymph-node syndrome (Kawasaki disease)

Authors:  A M Weindling; R J Levinsky; W C Marshall; J Hood
Journal:  Arch Dis Child       Date:  1979-03       Impact factor: 3.791

Review 3.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

4.  Lymphocyte subpopulations in anaphylactoid purpura.

Authors:  S Musumeci; A Sciotto; A Rosalba; S L Volti; F Mollica
Journal:  Arch Dis Child       Date:  1980-07       Impact factor: 3.791

Review 5.  Circulating immune complexes in dermatologic disease.

Authors:  T J Lawley; R P Hall
Journal:  Springer Semin Immunopathol       Date:  1981

6.  The use of C1q, conglutinin and low affinity rabbit IgM antibody to human Fc in a ligand coctail radioassay for detecting and characterizing immune complexes in pathological sera.

Authors:  G D Harkiss; D L Brown
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

7.  Damaged membrane fragments and immune complexes in the blood of patients with Behcet's syndrome.

Authors:  T Lehner; J D Almeida; R J Levinsky
Journal:  Clin Exp Immunol       Date:  1978-11       Impact factor: 4.330

8.  The value of three immune complex assays in the management of systemic lupus erythematosus: an assessment of immune complex levels, size and immunochemical properties in relation to disease activity and manifestations.

Authors:  S A Cairns; A London; N P Mallick
Journal:  Clin Exp Immunol       Date:  1980-05       Impact factor: 4.330

9.  Platelet-aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus.

Authors:  N Kasai; A Parbtani; J S Cameron; V Yewdall; P Shepherd; P Verroust
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

10.  Circulating immune complexes in pre-eclampsia.

Authors:  G M Stirrat; C W Redman; R J Levinsky
Journal:  Br Med J       Date:  1978-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.